Search results
Results from the WOW.Com Content Network
ZyCoV-D is a DNA plasmid-based COVID-19 vaccine developed by Indian pharmaceutical company Cadila Healthcare, with support from the Biotechnology Industry Research Assistance Council. It is approved for emergency use in India.
On 20 August 2021, India granted emergency authorization to Zydus Cadila's vaccine ZyCoV-D, the world's first DNA plasmid-based COVID-19 vaccine, for patients 12 and older. India granted emergency use approval to the world's first DNA based COVID-19 vaccine, manufactured by for adults and children aged 12 years and above. The vaccine is ...
A number of COVID‑19 vaccines began to become approved and available at scale in December 2020, with vaccinations beginning to ramp up at scale from the beginning of 2021, among them the Oxford–AstraZeneca COVID‑19 vaccine, based on an adenovirus vector and internally termed AZD1222.
In May 2022, the WHO report stated that there were 14.9 million deaths worldwide due to COVID-19 by the end of 2021, a figure that is 3 times higher than the official estimate of 5.4 million deaths. This WHO report reflect people who died of COVID-19 and also those who died as an indirect result of the virus.
Reporting standards vary enormously in different countries. No statistics are particularly accurate, but case and death rates in India (South Asia) and Sub-Saharan Africa in particular are probably much higher than reported. [27] [28] COVID-19 cases and deaths by region, in absolute figures and rates per million inhabitants as of 25 December ...
The first cases of COVID-19 in India were reported on 30 January 2020 in three towns of Kerala, among three Indian medical students who had returned from Wuhan, the epicenter of the pandemic. [ 10 ] [ 11 ] [ 12 ] Lockdowns were announced in Kerala on 23 March, and in the rest of the country on 25 March.
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA).
This template is used to provide data for COVID-19 vaccine, COVID-19 pandemic by country and territory, and Deployment of COVID-19 vaccines. References [ edit ]